Masimo’s long-time lawsuit over Apple Watch patent infringement has encountered one other setback, as a U.S. District Court docket submitting reveals the criticism in opposition to the USITC will likely be dismissed with prejudice.
The USITC’s (United States Worldwide Commerce Fee) choice to disclaim a reinstatement of a ban on the Apple Watch has changed into a hurdle for Masimo in its long-running blood oxygen patent lawsuit in opposition to Apple. In an April 24 submitting by the U.S. District Court docket for the District of Columbia, a criticism in opposition to the USITC a couple of ban has been handled.
The submitting, detailing a criticism between Masimo and the ITC, in addition to U.S. Customs and Border Safety, explains a quick historical past of the courtroom’s dealings with the ITC. Whereas it would not point out the Apple Watch immediately, it is all in regards to the patent infringement go well with with Apple and the implementation and dismissal of a ban.
On March 19, an Administrative Regulation Choose on the U.S. Court docket of Appeals for the Federal Circuit backed the unique ITC ruling from October 2023 that banned the Apple Watch from being imported into the US. Nonetheless, crucially for Apple and in the future earlier than the Appeals ruling, the ITC dominated that there was no level to implementing a second ban on the wearable.
One month later, on April 17, the ITC denied a request by Masimo to reinstate the ban, declining to overview the preliminary ruling and closed the case.
The brand new April 24 District Court docket states that each one events within the Masimo vs ITC and Customs and Border Safety criticism have agreed to dismiss it with prejudice. A “proposed stipulation of dismissal” will likely be filed sooner or later.
This doesn’t suggest the lawsuit is over, as is sort of all the time the case for high-profile and costly circumstances. Masimo can nonetheless attraction to the U.S. Court docket of Appeals for the Federal Circuit, with a deadline of a discover of attraction set for June 16, 2026.
For Apple, the submitting signifies that there is no fast danger of one other gross sales ban instigated by Masimo for the Apple Watch. It nonetheless would not permit Apple to revive coronary heart charge viewing on the Apple Watch, solely on the iPhone.
The story to this point
The lawsuit began in 2020, when Masimo filed with the U.S. District Court docket for the Central District of California. A criticism was filed to the ITC in 2021.
The unique lawsuit was a mistrial in 2023, nonetheless Masimo received the ITC case the identical 12 months. It then resulted in a banon U.S. imports of infringing Apple Watch,
A workaround within the type of a software program replace disabling the blood oxygen function in the US was sufficient to persuade the Customs and Border Safety Company to raise the ban in January 2024.
Later, in November 2025, Masimo received a $634 million verdict in a federal jury trial.
